Skip to content
value.today

OWP Pharmaceuticals, Inc.

Total raised
$5 M
2 rounds on record
Latest round
$2 M
Jul 2025
First round on record
Jun 2024
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of OWP Pharmaceuticals, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$2 MNo. 2$2 to $10 million

OWP Pharmaceuticals, Inc.: Raise no. 2, Jul 2025

Investors in this round

19 investors had bought by the notice of Sep 9, 2025: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Illinois

People named in the notice

  • Scott Boyer · Executive Officer, Director
  • Steve Bourne · Executive Officer
  • Bruce Duncan · Director
  • Kurt Florian · Director
  • Matt Litfin · Director
  • Troy Hammond · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Bourne, Cfo. Newest notice filed Sep 9, 2025. Read the notice at the SEC.

equitySEC
Jun 2024$3 MNo. 1$2 to $10 million

OWP Pharmaceuticals, Inc.: Raise no. 1, Jun 2024

Investors in this round

11 investors had bought by the notice of Sep 16, 2024: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Illinois

People named in the notice

  • Scott Boyer · Executive Officer, Director
  • Steve Bourne · Executive Officer
  • Bruce Duncan · Director
  • Carol Gavin · Director
  • Kurt Florian · Director
  • Paul Regan · Director
  • Troy Hammond · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Bourne, Cfo. Newest notice filed Sep 16, 2024. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • OWP Pharmaceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2025).

    SEC Form D · Sep 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of OWP Pharmaceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by OWP Pharmaceuticals, Inc.
NameRoleNamed in
Scott BoyerExecutive officerSep 2025
Steve BourneExecutive officerSep 2025
Bruce DuncanDirectorSep 2025
Kurt FlorianDirectorSep 2025
Matt LitfinDirectorSep 2025
Scott BoyerDirectorSep 2025
Troy HammondDirectorSep 2025
Carol GavinDirectorSep 2024
Paul ReganDirectorSep 2024